Phage Therapeutics International Inc – ‘10SB12G/A’ on 6/5/01 – EX-27

On:  Tuesday, 6/5/01, at 9:31pm ET   ·   As of:  6/6/01   ·   Accession #:  1096906-1-500109   ·   File #:  0-31961

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Amendment to Registration of Securities of a Small-Business Issuer   —   Form 10-SB
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10SB12G/A   Amendment to Registration of Securities of a          96    577K 
                          Small-Business Issuer                                  
 2: EX-3.(I)    Articles of Incorporation and Amendments               5     19K 
 3: EX-3.(II)   By-Laws                                               14     78K 
 4: EX-10.1     Advisory Agreements                                   11     68K 
 5: EX-10.2     Confidentiality Agreement                              2     11K 
 6: EX-10.3     Employee Agreements                                   47    237K 
 7: EX-10.4     Management Agreement                                   2     14K 
 8: EX-10.5     Property Lease Agreement                              26    138K 
 9: EX-10.6     Consulting Agreement                                   2±    11K 
10: EX-10.7     Stock Option Plan 2000                                17     85K 
11: EX-10.8     Securities Purchase Agreement                         28    139K 
12: EX-21       List of Subsidiaries                                   6     21K 
13: EX-27       Financial Data Schedule                                1     10K 

EX-27   —   Financial Data Schedule

                                                                [Download Table]
                                                                                

<ARTICLE>                     5                                                 
<LEGEND>                                                                        

THIS SCHEDULE  CONTAINS SUMMARY FINANCIAL  INFORMATION  EXTRACTED FROM MARCH 31,
2001  CONSOLIDATED  FINANCIAL  STATEMENTS  AND IS  QUALIFIED  IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS                                          
</LEGEND>                                                                       

                                                                                
<PERIOD-TYPE>                   3-MOS                                           
<FISCAL-YEAR-END>                        DEC-31-2000                            
<PERIOD-START>                            JAN-1-2001                            
<PERIOD-END>                             MAR-31-2001                            
<CASH>                                     1,515,593                            
<SECURITIES>                              10,895,444                            
<RECEIVABLES>                                      0                            
<ALLOWANCES>                                       0                            
<INVENTORY>                                        0                            
<CURRENT-ASSETS>                           1,795,941                            
<PP&E>                                       188,045                            
<DEPRECIATION>                               (55,682)                           
<TOTAL-ASSETS>                             2,058,986                            
<CURRENT-LIABILITIES>                        659,774                            
<BONDS>                                            0                            
<PREFERRED-MANDATORY>                              0                            
<PREFERRED>                                        0                            
<COMMON>                                  10,895,444                            
<OTHER-SE>                                 1,407,581                            
<TOTAL-LIABILITY-AND-EQUITY>               2,058,986                            
<SALES>                                            0                            
<TOTAL-REVENUES>                                   0                            
<CGS>                                              0                            
<TOTAL-COSTS>                                      0                            
<OTHER-EXPENSES>                            (610,704)                           
<LOSS-PROVISION>                                   0                            
<INTEREST-EXPENSE>                             9,935                            
<INCOME-PRETAX>                             (600,769)                           
<INCOME-TAX>                                       0                            
<INCOME-CONTINUING>                         (600,769)                           
<DISCONTINUED>                                     0                            
<EXTRAORDINARY>                                    0                            
<CHANGES>                                          0                            
<NET-INCOME>                                (600,769)                           
<EPS-BASIC>                                    (0.06)                           
<EPS-DILUTED>                                  (0.06)                           

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10SB12G/A’ Filing		Date		Other Filings
Filed as of:		6/6/01
Filed on:		6/5/01		8-K
		3/31/01		10-Q,  10-Q/A,  NT 10-Q
				List all Filings